Pharmaids Pharmaceuticals has informed that it enclosed the Audited Financial Results for the Quarter and Year ended March 31, 2022 along with the Auditor’s Report thereon, issued by the Statutory Auditors on Audited Financial Results and the Declaration, as required in terms of SEBI Circular No. CIR/CFD/CMD/56/2016 dated May 27, 2016. The said Financial Results have been approved by the Board of Directors of the Company at their Meeting held today May 21, 2022.
The above information is a part of company’s filings submitted to BSE.
